MindMed

MindMed is a psychedelic medicine biotech company that focuses on developing innovative treatments for addiction and mental illness. The company's drug development pipeline includes a range of psychedelic substances, such as Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company's mission is to develop groundbreaking psychedelic-inspired medicines and therapies that can help individuals recover from mental illnesses and addiction. MindMed aims to be at the forefront of the next generation of mental health treatments combining the latest advances in psychedelic medicine with modern technology and research methodologies.